[Unfrequently opportunistic infection in lupus erythematosus with inmunosuppresive treatment].
We present a case of systemic lupus erythematosus complicated by pancytopenia and visceral leishmaniasis in Spain. The literature on opportunistic infection in lupus erythematosus is reviewed.Leishmaniasis is a group of infections caused by the protozoa Leishmania, which is endemic in the Mediterranean basin. These opportunistic infections are an emerging entity in immunosuppressed patients. The use of immunosuppressive treatment in systemic lupus erythematosus modifies natural defense patterns and increases the risk of visceral leishmaniasis in endemic areas.
Pérez Silvestre
J
J
Sección de Reumatología y Metabolismo Oseo, Servicio de Medicina Interna, Hospital General Universitario, Valencia, Spain. jopesilver@hotmail.com
Campos Fernández
C
C
Calvo Catalá
J
J
González Cruz
M I
MI
Baixauli Rubio
A
A
Pastor Cubillo
D
D
D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D010198:Pancytopenia / Q000209:etiology; D013997:Time Factors
D000981:Antiprotozoal Agents; D000666:Amphotericin B